| 摘要 |
This invention relates to new RAR selective retinoid agonists of formula Iwherein the symbols are as defined in the specification to their pharmaceutically acceptable salts, individual isomers or to a racemic or non-racemic mixture; to pharmaceutical compositions containing them, and to methods for their use as therapeutic agents.
|
